Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Investors
Events
Vontobel Swiss Healthcare Tour 2010
November 8, 2010 - Basel, CH
Jefferies's 1st London Biopharma Conference
October, 5-6, 2010 - Waldorf Hilton, London
Boston Biotech CEO Conference
June 14-15, 2010 - Cambrigde, Massachusetts, USA
Jefferies' Global Life Sciences Conference.
June 8-11, 2010 - The Grand Hyatt, New York, US
Rodman & Renshaw Annual Global Investment Conference
May 16-18, 2010 - London, UK
Swiss Equity Biotech Day
April 13th, 2010 - SIX Swiss Exchange, ConventionPoint, Zurich, CH
Future Leaders in the Biotech Industry
April 8 - New York, USA
Bio Europe Spring 2010
March 8-10, 2010 - Barcelona, Spain
Credit Suisse One-on-One Healthcare Conference
March 2-4, 2010 - London, UK
12th Annual BIO CEO & Investor Conference
February 8-9, 2010 - New York, USA
7th Annual BIO Asia Partnering Conferenc
January 25-26, 2010- Tokyo, Japan
Helvea Swis Equities 2010 Conference
January 14 -15, 2010 - Bad Ragaz, CH
JPM Annual Healthcare Conference
January 11 - 14, 2010 - Westin St. Francis, San Francisco, US